Citigroup
WST icon

Citigroup’s West Pharmaceutical WST Stock Holding History

Citigroup’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,500
Closed -$1.38M – 7870
2019
Q1 		$1.38M Buy
+12,500
New +$1.3M ﹤0.01% 3048

Other funds holding WST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $39B AUM 34.13% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Citigroup's WST Position: Q3 2026 in Review

Citigroup increased its West Pharmaceutical (WST) stake by 17% in Q3 2026, buying an estimated $11.6M and bringing the position to 223,775 shares worth $83M. The position accounts for 0.03% of the portfolio, ranked #566.

Citigroup first reported a position in WST in Q2 2013 and has held it in 54 quarters since. 591 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Citigroup held 223,775 shares of West Pharmaceutical worth $83M as of Q3 2026.
  • Citigroup bought 32,997 West Pharmaceutical shares in Q3 2026, an estimated $11.6M.
  • West Pharmaceutical made up 0.03% of Citigroup's portfolio in Q3 2026, its #566 holding.
  • Citigroup first reported a position in West Pharmaceutical in Q2 2013 and has held it in 54 quarters since.
  • 591 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.